MAM
BSX icon

McLaughlin Asset Management’s Boston Scientific BSX Stock Holding History

McLaughlin Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Sell
8,684
-9,774
-53% -$531K 0.28% 80
2026
Q1 		$1.16M Buy
18,458
+12,272
+198% +$982K 1.11% 29
2025
Q4 		$590K Buy
+6,186
New +$606K 0.53% 61

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

McLaughlin Asset Management's BSX Position: Q2 2026 in Review

McLaughlin Asset Management reduced its Boston Scientific (BSX) stake by 53% in Q2 2026, selling an estimated $531K and leaving 8,684 shares worth $371K. The position accounts for 0.28% of the portfolio, ranked #80.

McLaughlin Asset Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.16M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • McLaughlin Asset Management held 8,684 shares of Boston Scientific worth $371K as of Q2 2026.
  • McLaughlin Asset Management sold 9,774 Boston Scientific shares in Q2 2026, an estimated $531K.
  • Boston Scientific made up 0.28% of McLaughlin Asset Management's portfolio in Q2 2026, its #80 holding.
  • McLaughlin Asset Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • McLaughlin Asset Management's Boston Scientific position peaked at $1.16M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on McLaughlin Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.